Measles and EMS: What Providers Need to Know

Measles is airborne, highly contagious, and present in Virginia. This guide covers clinical recognition, PPE requirements, field response steps, and everything your crew needs before encountering a case.

---

Measles was declared eliminated in the United States in 2000 — a milestone achieved through sustained vaccination coverage above 95%. That threshold is now slipping nationally as vaccine hesitancy grows and immunization rates decline. As coverage drops and international travel continues, measles will periodically appear in communities across Virginia.

EMS providers are often among the first clinicians to encounter a measles case, frequently without advance warning. The virus spreads through the air and can remain infectious in an enclosed space for up to two hours after an infected person has left. A single unprotected exposure can affect an entire crew and take a unit out of service for weeks during a quarantine period. Knowing the disease, your PPE, and your reporting obligations before you encounter it is not optional — it is operational readiness.

---

Measles presents in two distinct stages. The early prodrome phase often looks like a severe cold or flu and is easy to miss — or to mistake for influenza, COVID-19, or another febrile illness. Knowing both stages is critical because the patient is contagious before the rash ever appears.

---

Agencies with crew members who cannot safely fit-test on an N95 due to facial hair or other factors may use a powered air-purifying respirator (PAPR) with full hood and HEPA filter. If medically tolerated, place a surgical mask on the patient to reduce environmental contamination during transport.

---

1. Don PPE before patient contact. If dispatch receives a call describing rash plus fever — or the caller mentions measles — crews should don N95 respirators en route. Do not wait until you are at the bedside. The virus can be airborne in any enclosed space the patient has occupied.
2. Limit crew exposure. Only essential personnel should enter the patient’s immediate environment. When possible, assign a crew member with documented measles immunity to the primary patient contact role.
3. Notify the receiving facility before arrival. Call ahead so the emergency department can prepare an airborne infection isolation room (negative pressure). Per ODEMSA Protocol 3-1, timely pre-arrival notification is a standard expectation for all medical transports — measles cases make this step critical. Do not walk the patient through a waiting room or common area.
4. Manage supportively — minimize aerosol-generating procedures. There is no specific antiviral treatment for measles in the field. Management is supportive. Avoid aerosol-generating procedures unless clinically necessary. If required, wear full PPE — gown and face shield in addition to the N95.
5. Decontaminate the unit — time sensitive. After transport, the vehicle must sit with doors open for a minimum of 2 hours before being returned to service. This allows the airborne virus to die naturally on surfaces. Chemical decontamination alone does not inactivate measles, but complete your standard chemical decontamination process afterward to address other respiratory pathogens.
6. Complete an exposure report immediately. File the ODEMSA Infectious Disease Exposure Report and notify your agency’s Infection Control Officer and EMS Medical Director per your agency protocol. All exposed crew — including those with documented immunity — should monitor for symptoms for 21 days following the exposure. You may also refer to the ODEMSA Protocol 12-11, Infection Control.

---

A non-immune provider exposed to measles must quarantine from day 5 through day 21 after exposure — a potential 16-day removal from service. This represents a serious operational impact for any agency. All personnel are strongly encouraged to verify measles immunity status now, before an exposure occurs.

You are considered immune if you have documentation of any of the following:

---

---

There is no antiviral treatment for measles. Field management is supportive only — airway management, fever control, and transport. The MMR (measles, mumps, rubella) vaccine has been in widespread use since 1971, has been studied extensively over decades, and is safe and approximately 95% effective. Two doses provide lifetime protection.

Maintaining your own vaccination status protects not only yourself, but your entire crew, your patients, and the communities you serve. Agencies are encouraged to recommend that all personnel confirm their MMR vaccination history and that they speak with their healthcare provider about vaccination for Measles, Mumps, Rubella, Polio, Diphtheria, Tetanus, and other vaccine-preventable diseases — all of which are safe and recommended.

---